Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia

NCT07750730 is registered in ClinicalTrials.gov with Beijing Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT07750730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07750730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Clinical Efficacy and Peripheral Ultrasound Mechanism of Trigger Point Bloodletting Therapy for Primary Trigeminal Neuralgia
Lead sponsor
Beijing Hospital of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

trigeminal neuralgia (tn)